Sanofi SA (SNY)
49.29
+0.28
(+0.57%)
USD |
NASDAQ |
May 06, 16:00
49.33
+0.04
(+0.08%)
After-Hours: 20:00
Sanofi Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 18.12B |
September 30, 2023 | 0.00 |
June 30, 2023 | 20.58B |
March 31, 2023 | 0.00 |
December 31, 2022 | 20.41B |
September 30, 2022 | 0.00 |
June 30, 2022 | 19.85B |
March 31, 2022 | 0.00 |
December 31, 2021 | 22.99B |
September 30, 2021 | 0.00 |
June 30, 2021 | 23.99B |
March 31, 2021 | 0.00 |
June 30, 2020 | 26.69B |
March 31, 2020 | 0.00 |
December 31, 2019 | 27.65B |
September 30, 2019 | 0.00 |
June 30, 2019 | 28.99B |
March 31, 2019 | 0.00 |
December 31, 2018 | 28.19B |
September 30, 2018 | 0.00 |
June 30, 2018 | 33.46B |
March 31, 2018 | 0.00 |
December 31, 2017 | 18.72B |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 19.64B |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 18.10B |
September 30, 2015 | 0.00 |
June 30, 2015 | 16.52B |
March 31, 2015 | 0.00 |
December 31, 2014 | 18.01B |
September 30, 2014 | 0.00 |
June 30, 2014 | 20.19B |
March 31, 2014 | 0.00 |
December 31, 2013 | 20.15B |
September 30, 2013 | 0.00 |
June 30, 2013 | 19.11B |
March 31, 2013 | 0.00 |
December 31, 2012 | 19.22B |
September 30, 2012 | 0.00 |
June 30, 2012 | 20.13B |
March 31, 2012 | 0.00 |
December 31, 2011 | 20.00B |
September 30, 2011 | 0.00 |
June 30, 2011 | 29.01B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
28.99B
Maximum
Jun 2019
11.63B
Average
9.060B
Median
Total Long Term Debt (Quarterly) Benchmarks
AstraZeneca PLC | 33.31B |
GSK PLC | 22.44B |
Regeneron Pharmaceuticals Inc | 1.983B |
Cellectis SA | 33.61M |
Denali Therapeutics Inc | -- |